In short, despite some heterogeneity across the trials, GLP-1 receptor agonists were shown to reduce the hazard ratios [95%CI] for 3-MACE by 12 [618]%, cardiovascular death by 12 [419]%, myocardial infarction by 9 [016]% and stroke by 16 {724]%
This could influence treatment decisions and improve respiratory health in this high-risk population. GLP-1 medications might help lower COPD exacerbation risk by reducing systemic inflammation, improving metabolic function, and possibly having direct effects on lung tissue, she continued
Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro AL, Pronzato MA
& Yousefi, B
I see these in women who have been pregnant or in patients who have had a history of thrombosed external hemorrhoids